214 related articles for article (PubMed ID: 35996156)
41. Fatty Acid Oxidation in Peroxisomes: Enzymology, Metabolic Crosstalk with Other Organelles and Peroxisomal Disorders.
Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Adv Exp Med Biol; 2020; 1299():55-70. PubMed ID: 33417207
[TBL] [Abstract][Full Text] [Related]
42. A second isoform of 3-ketoacyl-CoA thiolase found in Caenorhabditis elegans, which is similar to sterol carrier protein x but lacks the sequence of sterol carrier protein 2.
Bun-Ya M; Maebuchi M; Hashimoto T; Yokota S; Kamiryo T
Eur J Biochem; 1997 Apr; 245(2):252-9. PubMed ID: 9151950
[TBL] [Abstract][Full Text] [Related]
43. Peroxisomes in adrenal steroidogenesis.
Magalhães MM; Magalhães MC
Microsc Res Tech; 1997 Mar; 36(6):493-502. PubMed ID: 9142695
[TBL] [Abstract][Full Text] [Related]
44. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643.
Arnauld S; Fidaleo M; Clémencet MC; Chevillard G; Athias A; Gresti J; Wanders RJ; Latruffe N; Nicolas-Francès V; Mandard S
Biochimie; 2009; 91(11-12):1376-86. PubMed ID: 19772884
[TBL] [Abstract][Full Text] [Related]
45. Effect of SCP-x gene ablation on branched-chain fatty acid metabolism.
Atshaves BP; McIntosh AL; Landrock D; Payne HR; Mackie JT; Maeda N; Ball J; Schroeder F; Kier AB
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G939-51. PubMed ID: 17068117
[TBL] [Abstract][Full Text] [Related]
46. Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids.
Baes M; Huyghe S; Carmeliet P; Declercq PE; Collen D; Mannaerts GP; Van Veldhoven PP
J Biol Chem; 2000 May; 275(21):16329-36. PubMed ID: 10748062
[TBL] [Abstract][Full Text] [Related]
47. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
Street JM; Singh H; Poulos A
Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
[TBL] [Abstract][Full Text] [Related]
48. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
49. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
Kohjima M; Enjoji M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Takayanagi R; Nakamuta M
Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
[TBL] [Abstract][Full Text] [Related]
50. [Peroxisomal beta-oxidation].
Mannaerts GP; Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1993; 55(1):45-78. PubMed ID: 8480447
[TBL] [Abstract][Full Text] [Related]
51. Lauric acid dependent enhancement in hepatic SCPx protein requires an insulin deficient environment.
Lopez D; Niesen M; Bedi M; McLean MP
Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):131-5. PubMed ID: 18187312
[TBL] [Abstract][Full Text] [Related]
52. Induction of peroxisomal lipid metabolism in mice fed a high-fat diet.
Kozawa S; Honda A; Kajiwara N; Takemoto Y; Nagase T; Nikami H; Okano Y; Nakashima S; Shimozawa N
Mol Med Rep; 2011; 4(6):1157-62. PubMed ID: 21850377
[TBL] [Abstract][Full Text] [Related]
53. Sterol carrier protein 2: a role in steroid hormone synthesis?
Pfeifer SM; Furth EE; Ohba T; Chang YJ; Rennert H; Sakuragi N; Billheimer JT; Strauss JF
J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):167-72. PubMed ID: 8274432
[TBL] [Abstract][Full Text] [Related]
54. Sterol carrier protein-2: new roles in regulating lipid rafts and signaling.
Schroeder F; Atshaves BP; McIntosh AL; Gallegos AM; Storey SM; Parr RD; Jefferson JR; Ball JM; Kier AB
Biochim Biophys Acta; 2007 Jun; 1771(6):700-18. PubMed ID: 17543577
[TBL] [Abstract][Full Text] [Related]
55. Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis.
Reddy JK
Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1333-9. PubMed ID: 11705737
[TBL] [Abstract][Full Text] [Related]
56. Peroxisomal beta-oxidation and steatohepatitis.
Rao MS; Reddy JK
Semin Liver Dis; 2001; 21(1):43-55. PubMed ID: 11296696
[TBL] [Abstract][Full Text] [Related]
57. Deficiency of a Retinal Dystrophy Protein, Acyl-CoA Binding Domain-containing 5 (ACBD5), Impairs Peroxisomal β-Oxidation of Very-long-chain Fatty Acids.
Yagita Y; Shinohara K; Abe Y; Nakagawa K; Al-Owain M; Alkuraya FS; Fujiki Y
J Biol Chem; 2017 Jan; 292(2):691-705. PubMed ID: 27899449
[TBL] [Abstract][Full Text] [Related]
58. Functional characterisation of peroxisomal β-oxidation disorders in fibroblasts using lipidomics.
Herzog K; Pras-Raves ML; Ferdinandusse S; Vervaart MAT; Luyf ACM; van Kampen AHC; Wanders RJA; Waterham HR; Vaz FM
J Inherit Metab Dis; 2018 May; 41(3):479-487. PubMed ID: 28849344
[TBL] [Abstract][Full Text] [Related]
59. Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism.
Blankestijn M; Bloks VW; Struik D; Huijkman N; Kloosterhuis N; Wolters JC; Wanders RJA; Vaz FM; Islinger M; Kuipers F; van de Sluis B; Groen AK; Verkade HJ; Jonker JW
Sci Rep; 2022 Feb; 12(1):2512. PubMed ID: 35169201
[TBL] [Abstract][Full Text] [Related]
60. Metabolic aspects of peroxisomal beta-oxidation.
Osmundsen H; Bremer J; Pedersen JI
Biochim Biophys Acta; 1991 Sep; 1085(2):141-58. PubMed ID: 1892883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
